生物制剂:特里巴拉提德和较新的合成代谢药
1Harishchandra Institute of Orthopaedics & Research, Allahabad, India.
Indian journal of orthopaedics
|December 18, 2023
概括
生物药物通过解决骨脆弱性机制,提供有针对性的骨质疏松症治疗. 未来的研究重点是精准医学,新的点和组合疗法,以改善骨折预防和生活质量.
科学领域:
- 整形外科 整形外科 整形外科
- 药理学 药理学是指药理学的学科.
- 骨生物学 骨生物学 骨生物学
背景情况:
- 骨质疏松症的治疗已经从传统疗法转向了先进的生物药物.
- 生物学家提供精确驱动的策略,针对骨脆弱的潜在机制.
研究的目的:
- 探索骨质疏松症护理中的生物干预的机制,应用和未来方向.
- 提供骨质疏松症管理的不断变化的景观的全面概述.
主要方法:
- 对各种生物药物的综述,包括核因子卡帕-B连接体 (RANKL) 抑制剂的受体激活剂,斯克莱洛斯抑制剂,甲状腺激素 (PTH) 类似物和甲素K抑制剂.
- 讨论潜在的益处,局限性,安全性和组合疗法.
- 探索在特定患者群体中的应用,生物标志物的作用和新目标.
主要成果:
- 生物药物展示了针对骨健康的有针对性的方法,彻底改变了骨质疏松症的治疗方法.
- 基于患者特征的组合疗法和量身定制的治疗方法显示出有前途.
- 新型标和药物输送系统的进展旨在提高治疗的有效性和方便性.
结论:
- 生物药物代表了骨质疏松症管理的重大进步,提供了个性化的治疗策略.
- 未来的方向包括精准医学,新的治疗点,以及用于增强骨折预防的组合疗法.
- 预计持续的研究将改变骨健康结果和患者的生活质量.
相关概念视频
Hormones and Bone Tissue
2.7K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
2.7K
Bone Disorders
3.5K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.5K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Tumor Immunotherapy
529
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
529
Osteoclasts in Bone Remodeling
3.0K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.0K
Transducer Mechanism: Enzyme-Linked Receptors
2.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.5K


